Renal Cancer

With a multidisciplinary approach that includes prevention, early detection, the use of standard and promising new therapies, participation in laboratory and clinical research, and extensive complementary care, the team at Hoag Family Cancer Institute provides cancer patients with every diagnostic and therapeutic advantage.

Hoag Family Cancer Institute has been the leader in Orange County in advancing the treatment of adult patients suffering from the various hematologic malignancies, including acute leukemia’s (myeloid and lymphoid), chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), Hodgkin’s Disease, Non-Hodgkin’s Lymphomas and multiple myeloma. Hoag physicians developed the first adult bone marrow transplant program in the County, and introduced the blockbuster treatment rituximab to the county in 1995, three years before it became commercially available.

For more information, call Hoag Family Cancer Institute at 949-764-5542.

Approximately 4% of renal (kidney) cancers are considered to be familial. There are a number of hereditary renal cancer syndromes, including von Hippel-Lindau, tuberous sclerosis, hereditary papillary renal carcinoma (HPRC), Birt-Hogg-Dubé, hereditary leiomyomatosis & renal cell carcinoma (HLRCC), familial renal oncocytoma and hereditary clear cell cancer. Renal cancer is also part Lynch syndrome, also known as hereditary non-polyposis colon cancer (HNPCC).

Features that suggest a possible hereditary cause include early age at diagnosis (under age 50), cancer in both kidneys and a family history of renal cancer. Genetic testing for hereditary renal cancer is available both commercially and on a research basis.

Find more details about Hoag’s Hereditary Cancer Program​, including a list of frequently asked questions, ​or contact us at hereditarycancer@hoag.org or at 949-764-5764.